ArticleJACC. CardioOncology2020

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.

Roberto Bolli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.